Delivery Order SPE2DB20D9156-SPE2DB25FH28F
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,316.57 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,754.56 by the Defense Logistics Agency on September 11, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This award leverages DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on September 18, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $111,757.17 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract, which has no set-aside designation, calls for the delivery of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $148,787.74 by the Defense Logistics Agency (DLA) on June 2, 2025. The delivery order, which is not subject to any set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. The place of performance is Park Ridge, Illinois, with an ultimate completion date of June 3, 2025. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, valued at $18,488.12. The delivery order, which carries no set-aside designation, is for Trikafta 100-50-75 mg/150 mg tablets, a prescription medication used in the treatment of cystic fibrosis. The order is scheduled for completion by August 27, 2025, with performance taking...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on August 18, 2025. The delivery order, which is effective through August 19, 2025, calls for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This award was issued without a set-aside designation, allowing the vendor to compete directly in the federal...
- SPE2DB20D9156Indefinite Delivery Contract
- SPE2DB20D9156-SPE2DB25FH28FDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on July 14, 2025. The delivery order, which is scheduled for completion by July 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499.99 million and valid through November 2026. The DLA relies on DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain to support medication and medical supply needs across Department of Defense healthcare facilities. As an established pharmaceutical wholesaler with a long history of federal contracting since 2001, the company has demonstrated consistent capability in delivering branded and generic prescription drugs, biologics, and specialized pharmaceutical products to military health systems. This delivery order for Trikafta, a prescription medication used in treating cystic fibrosis, exemplifies the company's role in ensuring timely access to critical medications for beneficiaries across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 7/14/25 |